198 related articles for article (PubMed ID: 35007465)
1. Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United Kingdom.
Matthijsse S; Andersson FL; Gargano M; Yip Sonderegger YL
J Med Econ; 2022; 25(1):129-137. PubMed ID: 35007465
[TBL] [Abstract][Full Text] [Related]
2. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India.
Cook JR; Saxena K; Taylor C; Jacobs JL
BMC Health Serv Res; 2023 Mar; 23(1):267. PubMed ID: 36932411
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of Carbetocin versus Oxytocin for Prevention of Postpartum Hemorrhage Resulting from Uterine Atony in Women at high-risk for bleeding in Colombia.
Gil-Rojas Y; Lasalvia P; Hernández F; Castañeda-Cardona C; Rosselli D
Rev Bras Ginecol Obstet; 2018 May; 40(5):242-250. PubMed ID: 29913541
[TBL] [Abstract][Full Text] [Related]
5. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Williams HM; Price MJ; Merriel A; Gee H; Lissauer D; Moorthy V; Tobias A; Deeks JJ; Widmer M; Tunçalp Ö; Gülmezoglu AM; Hofmeyr GJ; Coomarasamy A
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011689. PubMed ID: 29693726
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of carbetocin for prevention of postpartum hemorrhage in a low-burden high-resource city of China.
You JHS; Leung TY
PLoS One; 2022; 17(12):e0279130. PubMed ID: 36520799
[TBL] [Abstract][Full Text] [Related]
7. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Apr; (4):CD005457. PubMed ID: 22513931
[TBL] [Abstract][Full Text] [Related]
8. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
[TBL] [Abstract][Full Text] [Related]
9. Clinical and financial evaluation of carbetocin as postpartum haemorrhage prophylaxis at caesarean section: A retrospective cohort study.
Wohling J; Edge N; Pena-Leal D; Wang R; Mol BW; Dekker G
Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):501-507. PubMed ID: 30411314
[TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study evaluating the cost-effectiveness of carbetocin for prevention of postpartum haemorrhage in caesarean sections.
Luni Y; Borakati A; Matah A; Skeats K; Eedarapalli P
J Obstet Gynaecol; 2017 Jul; 37(5):601-604. PubMed ID: 28317421
[TBL] [Abstract][Full Text] [Related]
11. Intramuscular oxytocin versus Syntometrine
van der Nelson H; O'Brien S; Burnard S; Mayer M; Alvarez M; Knowlden J; Winter C; Dailami N; Marques E; Burden C; Siassakos D; Draycott T
BJOG; 2021 Jun; 128(7):1236-1246. PubMed ID: 33300296
[TBL] [Abstract][Full Text] [Related]
12. Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: An economic impact analysis.
van der Nelson HA; Draycott T; Siassakos D; Yau CWH; Hatswell AJ
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():286-291. PubMed ID: 28088109
[TBL] [Abstract][Full Text] [Related]
13. Cost Implications of Using Carbetocin Injection to Prevent Postpartum Hemorrhage in a Canadian Urban Hospital.
Barrett J; Ko S; Jeffery W
J Obstet Gynaecol Can; 2022 Mar; 44(3):272-278. PubMed ID: 34656769
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin agonists for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005457. PubMed ID: 17636798
[TBL] [Abstract][Full Text] [Related]
15. Current research on carbetocin and implications for prevention of postpartum haemorrhage.
Theunissen FJ; Chinery L; Pujar YV
Reprod Health; 2018 Jun; 15(Suppl 1):94. PubMed ID: 29945640
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of carbetocin as prophylaxis for postpartum hemorrhage in the Philippines.
Briones JR; Talungchit P; Thavorncharoensap M; Chaikledkaew U
BMC Health Serv Res; 2020 Oct; 20(1):975. PubMed ID: 33106169
[TBL] [Abstract][Full Text] [Related]
17. Intravenous carbetocin versus intravenous oxytocin for preventing atonic postpartum hemorrhage after normal vaginal delivery in high-risk singleton pregnancies: a triple-blind randomized controlled trial.
Amornpetchakul P; Lertbunnaphong T; Boriboonhiransarn D; Leetheeragul J; Sirisomboon R; Jiraprasertwong R
Arch Gynecol Obstet; 2018 Aug; 298(2):319-327. PubMed ID: 29916110
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of prophylactic carbetocin versus oxytocin following vaginal delivery for preventing severe postpartum hemorrhage.
Korb D; Lopez R; Hörlin AL; Schmitz T; Borie C; Sibony O
Int J Gynaecol Obstet; 2023 Sep; 162(3):889-894. PubMed ID: 36825331
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of carbetocin in the prevention of postpartum hemorrhage: a systematic review and Bayesian meta-analysis of randomized trials.
Kalafat E; Gokce A; O'Brien P; Benlioglu C; Koc A; Karaaslan O; Khalil A
J Matern Fetal Neonatal Med; 2021 Jul; 34(14):2303-2316. PubMed ID: 31537134
[TBL] [Abstract][Full Text] [Related]
20. Carbetocin versus oxytocin for prevention of postpartum hemorrhage after vaginal delivery in high risk women.
Maged AM; Hassan AM; Shehata NA
J Matern Fetal Neonatal Med; 2016; 29(4):532-6. PubMed ID: 25731657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
